Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acotiamide vs Itopride in Postprandial Distress Syndrome
NCT07174297Phase 3Not yet recruiting
- Sponsor
- Getz Pharma
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of acotiamide in Postprandial Distress Syndrome (PDS), sponsored by Getz Pharma. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
acotiamide
03
Conditions
Postprandial Distress Syndrome (PDS)
Beyond the preview
Go deeper on NCT07174297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07174297.